Table Filtering
Other Information
Release Statistics Download
GlyCosmos Glycolipids

Glycolipid entries from the LIPID MAPS Structure Database (LMSD).

Source Last Updated
LIPID MAPS Proteome Database (LMSD)
Displaying entries 1951 - 1975 of 6046 in total
Sub Class LM ID Name LipidBank ID KEGG ID PubChem CID ChEBI ID Exact Mass ▲ Formula
Diacylglycerophosphoinositolglycans LMGP15010239
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-(9Z,12Z-nonadecadienoyl)-2-(9Z,12Z-hexadecadienoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM5(19:2(9Z,12Z)/16:2(9Z,12Z))
126457607 1654.774308 C74H127O38P
Gangliosides LMSP0601AH08
  • NeuAcalpha2-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
44262027 1655.986212 C81H145N3O31
Gangliosides LMSP0601AP08
  • GM1(d18:1/26:1(17Z))
  • Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
44262091 1655.986212 C81H145N3O31
Gangliosides LMSP0601AY08
  • GM1b(d18:1/26:1(17Z))
  • NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
44262163 1655.986212 C81H145N3O31
Gangliosides LMSP0601BM08
  • GM1alpha(d18:1/26:1(17Z))
  • Galbeta1-3(NeuAcalpha2-6)GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
44262275 1655.986212 C81H145N3O31
Gangliosides LMSP0601DK08
  • NeuAcalpha2-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
  • sialyl-lactotetraosylceramide(d18:1/26:1(17Z))
44262635 1655.986212 C81H145N3O31
Gangliosides LMSP0601DY08
  • NeuAcalpha2-6Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
  • sialyl(2-6)lactotetraosylceramide(d18:1/26:1(17Z))
44262739 1655.986212 C81H145N3O31
Gangliosides LMSP0601DZ08
  • Galbeta1-3(NeuAcalpha2-6)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
44262747 1655.986212 C81H145N3O31
Gangliosides LMSP0601ED08
  • NeuAcalpha2-6Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
44262779 1655.986212 C81H145N3O31
Gangliosides LMSP0601EF08
  • NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
  • sialosylparagloboside(d18:1/26:1(17Z))
44262795 1655.986212 C81H145N3O31
Diacylglycerophosphoinositolglycans LMGP15010233
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-(9Z-nonadecenoyl)-2-(9Z,12Z-hexadecadienoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM5(19:1(9Z)/16:2(9Z,12Z))
126457601 1656.789958 C74H129O38P
Diacylglycerophosphoinositolglycans LMGP15010238
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-(9Z,12Z-nonadecadienoyl)-2-(9Z-hexadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM5(19:2(9Z,12Z)/16:1(9Z))
126457606 1656.789958 C74H129O38P
Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) LMSP0504AI08
  • Fucalpha1-2Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
  • Leb(d18:1/26:1(17Z))
44260683 1657.006613 C82H148N2O31
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505AG08
  • Fucalpha1-2Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
  • Ley-6(d18:1/26:1(17Z))
44261027 1657.006613 C82H148N2O31
Gangliosides LMSP0601AH06
  • NeuAcalpha2-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0)
44262025 1658.001862 C81H147N3O31
Gangliosides LMSP0601AP06
  • GM1(d18:1/26:0)
  • Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/26:0)
44262089 1658.001862 C81H147N3O31
Gangliosides LMSP0601AY06
  • GM1b(d18:1/26:0)
  • NeuAcalpha2-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0)
44262161 1658.001862 C81H147N3O31
Gangliosides LMSP0601BM06
  • GM1alpha(d18:1/26:0)
  • Galbeta1-3(NeuAcalpha2-6)GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0)
44262273 1658.001862 C81H147N3O31
Gangliosides LMSP0601DK06
  • NeuAcalpha2-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0)
  • sialyl-lactotetraosylceramide(d18:1/26:0)
44262633 1658.001862 C81H147N3O31
Gangliosides LMSP0601DY06
  • NeuAcalpha2-6Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0)
  • sialyl(2-6)lactotetraosylceramide(d18:1/26:0)
44262737 1658.001862 C81H147N3O31
Gangliosides LMSP0601DZ06
  • Galbeta1-3(NeuAcalpha2-6)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0)
44262745 1658.001862 C81H147N3O31
Gangliosides LMSP0601ED06
  • NeuAcalpha2-6Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0)
44262777 1658.001862 C81H147N3O31
Gangliosides LMSP0601EF06
  • NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0)
  • sialosylparagloboside(d18:1/26:0)
44262793 1658.001862 C81H147N3O31
Diacylglycerophosphoinositolglycans LMGP15010227
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-nonadecanoyl-2-(9Z,12Z-hexadecadienoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM5(19:0/16:2(9Z,12Z))
126457595 1658.805608 C74H131O38P
Diacylglycerophosphoinositolglycans LMGP15010232
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-(9Z-nonadecenoyl)-2-(9Z-hexadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM5(19:1(9Z)/16:1(9Z))
126457600 1658.805608 C74H131O38P

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024